Senaparib Group:None

2 trials

Sponsors

The First Affiliated Hospital Of Anhui Medical University, The Second Affiliated Hospital of Xi' an Jiaotong University

Conditions

First-line maintenance therapy in newly diagnosed advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer patientsLate-stage ovarian, fallopian tube, or primary peritoneal cancer

Phase 4

A real-world study on Senaparib for first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer,fallopian tube cancer,or primary peritoneal cancer

RecruitingChiCTR2600129532

The Second Affiliated Hospital of Xi' an Jiaotong UniversityLate-stage ovarian, fallopian tube, or primary peritoneal cancer

Start: 2026-04-17Updated: 2026-08-10

Unknown Phase

A real-world study of first-line maintenance therapy with senaparib in newly diagnosed advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer

Active, not recruitingChiCTR2600127770

The First Affiliated Hospital Of Anhui Medical UniversityFirst-line maintenance therapy in newly diagnosed advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer patients

Start: 2026-07-07Updated: 2026-07-13